112 related articles for article (PubMed ID: 7738273)
1. Gamma-interferon therapy for severe cases of atopic dermatitis of the adult type.
Nishioka K; Matsunaga T; Katayama I
J Dermatol; 1995 Mar; 22(3):181-5. PubMed ID: 7738273
[TBL] [Abstract][Full Text] [Related]
2. Recombinant interferon gamma therapy for atopic dermatitis.
Hanifin JM; Schneider LC; Leung DY; Ellis CN; Jaffe HS; Izu AE; Bucalo LR; Hirabayashi SE; Tofte SJ; Cantu-Gonzales G
J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):189-97. PubMed ID: 8432915
[TBL] [Abstract][Full Text] [Related]
3. The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic dermatitis. A possible criterion for selection of patients for interferon therapy.
Gruner S; Liebenthal C; Heusser C; Brinkmann V; Zwirner A; Reinicke C; Harnack K; Sönnichsen N; Volk HD
Acta Derm Venereol; 1991; 71(6):484-7. PubMed ID: 1685830
[TBL] [Abstract][Full Text] [Related]
4. Systemic interferon gamma treatment in severe atopic dermatitis.
Reinhold U; Kukel S; Brzoska J; Kreysel HW
J Am Acad Dermatol; 1993 Jul; 29(1):58-63. PubMed ID: 8315079
[TBL] [Abstract][Full Text] [Related]
5. Blood eosinophils and serum IgE as predictors for prognosis of interferon-gamma therapy in atopic dermatitis.
Noh GW; Lee KY
Allergy; 1998 Dec; 53(12):1202-7. PubMed ID: 9930598
[TBL] [Abstract][Full Text] [Related]
6. Polydesensitisation with reducing elevated serum total IgE by IFN-gamma therapy in atopic dermatitis: IFN-gamma and polydesensitisation (PDS).
Lee JH; Noh G
Cytokine; 2013 Oct; 64(1):395-403. PubMed ID: 23786862
[TBL] [Abstract][Full Text] [Related]
7. Antigen presenting cell-independent cytokine and spontaneous in vitro IgE production in patients with atopic dermatitis: increased interferon-gamma production and lack of effects of in vivo low-dose interferon-gamma treatment.
Simon MR; Cooper KD; Norris RB; Blok B; King CL
J Allergy Clin Immunol; 1995 Jul; 96(1):84-91. PubMed ID: 7622767
[TBL] [Abstract][Full Text] [Related]
8. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels.
Boguniewicz M; Jaffe HS; Izu A; Sullivan MJ; York D; Geha RS; Leung DY
Am J Med; 1990 Apr; 88(4):365-70. PubMed ID: 2109531
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma for treatment of severe atopic eczema in two children.
Horneff G; Dirksen U; Wahn V
Clin Investig; 1994 May; 72(5):400-3. PubMed ID: 8086777
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels.
Stevens SR; Hanifin JM; Hamilton T; Tofte SJ; Cooper KD
Arch Dermatol; 1998 Jul; 134(7):799-804. PubMed ID: 9681342
[TBL] [Abstract][Full Text] [Related]
11. Characterization of children with recurrent eczema herpeticum and response to treatment with interferon-gamma.
Darji K; Frisch S; Adjei Boakye E; Siegfried E
Pediatr Dermatol; 2017 Nov; 34(6):686-689. PubMed ID: 29144049
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferon-gamma in severe atopic dermatitis.
Reinhold U; Wehrmann W; Kukel S; Kreysel HW
Lancet; 1990 May; 335(8700):1282. PubMed ID: 1971349
[No Abstract] [Full Text] [Related]
13. Interferon-alpha therapy in atopic dermatitis.
Torrelo A; Harto A; Sendagorta E; Czarnetzki BM; Ledo A
Acta Derm Venereol; 1992 Sep; 72(5):370-2. PubMed ID: 1361287
[TBL] [Abstract][Full Text] [Related]
14. Atopic dermatitis: the role of recombinant interferon-gamma therapy.
Chang TT; Stevens SR
Am J Clin Dermatol; 2002; 3(3):175-83. PubMed ID: 11978138
[TBL] [Abstract][Full Text] [Related]
15. [Human recombinant interferon gamma in the treatment of atopic dermatitis].
Musiał J; Milewski M; Undas A; Kopiński P; Duplaga M; Szczeklik A
Pol Arch Med Wewn; 1994 Dec; 92(6):499-506. PubMed ID: 7716053
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma. A potential role in the treatment of severe atopic dermatitis.
Reinhold U
Int J Dermatol; 1991 Jul; 30(7):477-8. PubMed ID: 1769767
[No Abstract] [Full Text] [Related]
17. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma.
Jang IG; Yang JK; Lee HJ; Yi JY; Kim HO; Kim CW; Kim TY
J Am Acad Dermatol; 2000 Jun; 42(6):1033-40. PubMed ID: 10827410
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis.
Habu Y; Seki S; Takayama E; Ohkawa T; Koike Y; Ami K; Majima T; Hiraide H
J Immunol; 2001 May; 166(9):5439-47. PubMed ID: 11313381
[TBL] [Abstract][Full Text] [Related]
19. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization.
Hattori K; Nishikawa M; Watcharanurak K; Ikoma A; Kabashima K; Toyota H; Takahashi Y; Takahashi R; Watanabe Y; Takakura Y
J Immunol; 2010 Mar; 184(5):2729-35. PubMed ID: 20107184
[TBL] [Abstract][Full Text] [Related]
20. Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.
Brar K; Leung DY
Expert Opin Biol Ther; 2016; 16(4):507-14. PubMed ID: 26694988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
